S

Serif Biomedicines

Develops non-viral, AI-guided modified DNA therapeutics

Associate Scientist - Bioanalytical Assays

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeCambridge, MA, USAIn-person

About the Job

Requirements

  • A Master's degree or bachelor's degree in a relevant discipline, with at least 6 years of industry experience.
  • Deep expertise in ex-vivo analytical assays such as enzyme-linked immunosorbent assay, mesoscale discovery, quantitative polymerase chain reaction, and droplet digital polymerase chain reaction.
  • Hands-on experience with multi-parameter flow cytometry, including panel design, compensation, and analysis.
  • Proficiency in processing tissues and isolating cell types such as hepatocytes and immune cells from mice and non-human primates.
  • Strong communication, interpersonal, organizational, analytical, and problem-solving skills.
  • Flexibility to support accelerated timelines associated with data generation, analysis, and reporting for in-vivo studies.
  • Ability to work in a fast-paced, multidisciplinary, and rapidly growing biotechnology environment.

Responsibilities

  • Execute and analyze bioassays to assess the efficacy, safety, and biodistribution of novel nucleic acid therapeutics in rodents and non-human primates.
  • Contribute scientific and technical perspectives to advance platform development.
  • Develop, optimize, and execute ligand-binding assays to support studies conducted in-house and at contract research organizations.
  • Communicate experimental findings in oral, written, and visual formats.
  • Work independently and collaboratively in a multidisciplinary team environment.

Desired Qualifications

  • Experience with various transfection methods in human and non-human primate peripheral blood mononuclear cells.
  • Prior experience in nucleic acid therapeutics or lipid nanoparticles.
  • Experience analyzing histological techniques such as immunohistochemistry/immunofluorescence, in-situ hybridization, and hematoxylin and eosin staining.

About the Company

Serif Biomedicines

Develops non-viral, AI-guided modified DNA therapeutics

Draft a concise summary of Serif Biomedicines including what it does, how its Modified DNA platform works, how it differs from competitors, and its goal, written for a high school audience.

Company size
51-200
Company stage
Early VC
Total funding
$50M
Headquarters
Cambridge, MA
Founded
2021

Recently Posted Jobs

Explore more opportunities at Serif Biomedicines

See more jobs